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Abstract 
Orofacial pain (OFP) is known to exert profound impacts on quality of life 
including functionally and psychosocially mediated changes in dietary intake 
and thereby nutrition. This commentary explores the evidence base available 
on chronic orofacial pain, diet and nutrition and discusses current dietary 
guidance for individuals with chronic OFP; potential impact of chronic OFP on 
eating and nutritional status; impact of nutritional status on pathophysiology of 
chronic OFP; potential role of nutrition in the management of chronic OFP. 
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Introduction 
The face and mouth are essential to our everyday lives. They provide us with 
verbal and non-verbal communicatory capacity, house the majority of our 
senses, and also allow us to eat and drink to satisfy our nutritional needs. 
Without adequate nutrient intake, malnutrition and nutrient deficiencies can 
occur. The oral cavity can be considered a sensitive barometer to the 
presentation of some of these diseases and therefore oral health care 
providers have been trained to identify their oral soft tissue clinical 
presentations.   
 
A body of evidence demonstrates that compromised oral health through either 
tooth loss and or oral mucosal disease is associated with increased risk of 
malnutrition (1-7). The potentially bidirectional relationship between chronic 
orofacial pain (OFP) and diet has, however, received less attention with only a 
few identifiable papers in the literature (8-14, 14).  
 
Many conditions cause pain in the orofacial region (15). A simple way of sub-
classifying these conditions is into acute (short-term) pain and those with the 
propensity for pain to be chronic (long-term, >3 months) pain (16). Acute OFP 
conditions may cause short-term changes in dietary intake, but chronic OFP 
has the potential to exert a more sustained change in dietary intake, which 
may affect the nutritional status of the individual. Chronic OFP is also more 
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likely to have a much greater (psychosocial) impact on individuals (17). The 
remainder of this commentary will therefore focus on examining the potential 
impact of chronic OFP on dietary intake and also the role nutrition/nutrients 
may play in the pathophysiology and management of the common conditions 
comprising chronic OFP: Temporomandibular Disorders (TMDs), Burning 
Mouth Syndrome (BMS), Persistent Dentoalveolar Pain disorder (PDAP), and 
Trigeminal Neuralgia (TN). 
 
The areas of discussion will include reviewing the: current dietary guidance for 
individuals with chronic OFP; potential impact of chronic OFP on eating and 
nutritional status; impact of nutritional status on pathophysiology of chronic 
OFP; and potential role of diet and nutrition in the management of chronic 
OFP. 
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Dietary Guidance for Chronic OFP  
There is a lack of evidence-based dietary guidelines for patients with chronic 
OFP. The most prudent and pragmatic current advice is to ask patients about 
their difficulty eating and provide customised dietary guidance based on the 
challenges the individuals report. Clinicians should try to avoid over-
simplifying the advice by for instance describing the need to take a “soft diet” 
when suffering from Temporomandibular Disorders (18-20). If this over-
simplified advice were taken verbatim it may lead to a reduced intake of whole 
grains, fresh fruits and vegetables or over-processing/cooking of food to 
soften it, thereby losing nutritional value. Instead of a generic “soft diet” 
clinicians could consider different methods to help decrease masticatory force 
but maintain the nutritional value of the food eaten. As an example, “soft 
bread buns/rolls” require more jaw movement to bite, chew and swallow than 
foods such as popcorn kernals or chopped tomatoes, all of which have more 
dietary fibre than most soft forms of bread (21). 
 
Neuropathic / neurovascular and musculoskeletal OFP conditions differ in 
their clinical management and potential impact on eating. The functional 
limitation of musculoskeletal conditions may mean that many normal 
movements required during mastication may cause or exacerbate the pain. 
This results in a desire to manipulate foods to help address the decreased 
function. For example, if mouth opening and chewing are difficult because of 
pain, then clinicians could advise alternative dietary choices or food 
preparation, such as peeling and cutting fruit, to help allow a balanced diet.    
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In neuropathic and neurovascular disorders, the food composition or 
temperature may exacerbate or play or role in triggering pain. In Trigeminal 
Neuralgia it may be related to food temperature whereas in Migraine it may be 
the presence of caffeine or tyramine in foods that trigger the pain.   
 
The impact of chronic OFP on the eating experience and 
nutritional status 
Pain provides a large proportion of the symptom burden in chronic OFP 
conditions, but there can also be a concomitant decrease in oral functional 
ability (22). The decrease in functional ability in TMD can be mediated by fear 
of movement (23), by the pain itself, or simply through an inability to open 
one’s mouth fully and chew with the same efficacy (22). The physiological and 
psychological impacts of OFP may also impact on the enjoyment of eating 
and subsequently quality of life, but there is a dearth of information on this 
important topic (17, 24, 25). 
 
The symptom burden of the OFP condition may alter both the choice and the 
preparation of food, but data on this are limited. Data for patients with TMD, 
from several decades ago, suggest that meat, apples, and bread might be 
frequently omitted from the diet (26) and some more recent data have 
suggested that vegetables and meat might be prepared differently using softer 
cooking methods (9). Furthermore, research in females with TMD suggested 
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that women with higher pain visual analogue scores (VAS) avoided fibre-rich 
foods more than those with lower VAS scores (13).  
 
If those suffering from chronic OFP that is musculoskeletal in origin choose to 
exclude foods, such as vegetables, wholegrain foods and dietary fibre then 
dietary sources of antioxidant vitamins, minerals, and other phytonutrients 
may be lacking. Emerging evidence suggests that many of these 
micronutrients have a role in attenuating chronic pain (27) and therefore it is 
plausible that a reduced intake may compound the OFP. There is, however, a 
dearth of data on the impact of OFP on the intake of macro and micronutrients 
and it is not known if dietary alterations over time, lead to changes in 
nutritional status and subsequent systemic health. 
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Impact of nutritional status on pathophysiology of chronic OFP 
Knowledge on the pathophysiology of chronic OFP is improving, but we still 
lack definitive conclusions. In chronic OFP of an inflammatory origin such as 
arthrogenous TMD it is plausible that antioxidant status may play a role in the 
pathophysiology of the condition.  Vitamins C, D, and E, soy, carotenoids and 
an array of dietary flavonoids, have been shown to have antioxidant 
properties and anti-hyperalgesic effects (28-32). The mechanisms by which 
antioxidants protect biological systems from free radical damage include the 
direct scavenging of reactive oxygen species and by the sequestration of free 
catalytic metal ions, which promote the formation of free radicals, inhibition of 
nuclear factor kappaB, inhibition of the cyclooxygenase pathway and 
reduction of lipid perioxidation (33, 34). In addition to antioxidant nutrients, the 
fatty acid profile of the diet may also impact the inflammatory processes 
associated with OFP. Omega 3 fatty acids (e.g., docosohexanoic acid and 
eicosapentanoic acid) have an established role in dampening inflammation by 
reducing the synthesis of pro-inflammatory prostaglandins (PGE2) and 
leukotriene B4; however the impact on OFP is unknown.  
 
Given that B vitamins such as folic acid have been closely linked to primary 
BMS (35-38) and alcoholic neuropathy (39, 40) it is plausible that select B 
vitamins (e.g., folic acid, vitamin B12) may play a role in neuropathic OFP 
conditions’ development, persistence, or management. There is also some 
preliminary evidence that micronutrient deficiencies of Vitamin C and Zinc 
may represent a risk factor for post-herpetic neuralgia (41). Extrapolating 
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further, there is limited evidence in experimentally induced neuropathic pain in 
animals, that changes to dietary intake particularly in relation to soy and 
omega fatty acids can help decrease neuropathic pain (12, 42-44). Soy 
contains flavonoids that have antioxidant and anti-inflammatory properties 
(27) and animal studies have shown genistein, a soy isoflavone, attenuates 
heat hyperalgesia associated with neuropathic pain (45).  
 
A large proportion of the evidence cited in favour of nutrition’s potential role in 
the pathophysiology of chronic OFP has been either based on in vitro findings, 
animal studies, or weak clinical evidence such as observational studies. 
Randomised controlled trials (RCTs) examining diet and nutritional 
interventions in chronic OFP can be interpreted as mechanistic trials that test 
the importance of nutrition in the aetiology of chronic OFP.  
 
Given the potential for RCTs involving diet and nutritional interventions to be 
interpreted as mechanistic trials we examined the literature for such trials 
involving TMD, BMS, PDAP, and TN. Table 1 summarises the total number of 
studies identified for each type of chronic OFP using the Cochrane 
handbook’s (46)  “highly sensitive search strategy (sensitivity-maximizing 
version)” for RCTs involving TMD, BMS, PDAP, and or TN patients in 
MEDLINE (1966 to 7 July 2014 limited to English language and human 
studies, search strategy available upon request). The first author read the 
abstracts of all studies identified by the search strategy and proceeded to 
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read the paper if the abstract indicated that a nutritional or dietary intervention 
was one of the arms of a RCT in either TMD, BMS, PDAP, or TN.  
 
RCTs involving dietary or nutritional interventions were only found for Burning 
Mouth Syndrome (Table 1). Of the six RCTs identified, four involved alpha-
lipoic acid (47-50), one involved Capsaicin (51), and one involved lycopene 
enriched virgin olive oil (52).  
 
There was conflicting evidence for the role of alpha-lipoic acid in the 
management of burning mouth syndrome with two studies (48, 50) suggesting 
a reduction in pain, both in combination with, and without Gabapentin, and 
two other studies (47, 49) suggesting no effect for alpha-lipoic acid as a 
stand-alone therapy. All studies suffered from varying methodological flaws 
including: propensity for type II errors; quasi-randomisation; lack of follow-up 
and or intention-to-treat-analysis; inadequate blinding.  
 
Lycopene-enriched virgin oil proved to perform no better than placebo when 
trialled (52) and Capsaicin proved to be better than placebo in reducing pain 
(51), however both the Lycopene and Capsaicin studies have significant 
methodological flaws similar to those affecting the alpha-lipoic acid studies. 
Given the scarcity of evidence and its somewhat contradictory and poor-
quality nature any role for nutrition in the pathophysiology of chronic OFP still, 
therefore, remains undetermined. 
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Potential role for nutrition in the management of chronic OFP  
The evidence base for the management of chronic OFP is generally of a poor 
quality and systematic reviews repeatedly call for new high-quality trials using 
homogenous samples and standardised patient-centred outcome measures 
(53). One area of consensus is the initial conservative reversible management 
of TMD (54) (55) which includes self-care and education alongside cognitive 
behavioural techniques. Most other chronic OFP conditions (56, 57) would 
also mandate self-care, education and cognitive behavioural techniques in 
one form or another. It is reasonable to suggest that optimising a patient’s diet 
with reference to the limitations of their pain condition might be incorporated 
into this. 
Attempting to optimise the patient’s diet with reference to their (functional) 
limitations may help avoid otherwise anecdotal suggestions from clinicians: 
resting the jaw (“soft diet” in TMDs), or avoiding certain foods which are 
considered to exacerbate the condition. Advice such as this, if provided, is 
‘blind’ to the possible impact that following such advice might have on 
nutritional status and longer-term health. The term “soft diet” is debatable at 
best and may be interpreted differently by patients and various health 
professionals. As previously indicated the aim is to reduce mandibular 
workload and as such any foods that may be cut, chopped or pureed would 
accomplish this independent of their initial texture. 
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The major classes of systemic pharmacological agents used to manage 
chronic OFP include: antidepressants (serotonin norepinephrine re-uptake 
inhibitors, tricyclic antidepressants), anticonvulsants (Gabamimetics and 
Sodium channel blockers), analgesics (Paracetamol [acetaminophen], 
NSAIDs), and corticosteroids. All of these pharmacological agents can exert 
side effects relevant to diet and nutrition. These include: peptic ulceration, 
alteration in weight, and gastrointestinal disturbance including nausea or 
constipation.  It is therefore important that management of the patient includes 
regular screening for these symptoms as they may lead to poor dietary 
choices.  
 
Patients should be referred to a registered dietician if they are 
experiencing: difficulty eating an adequate and varied diet, weight change, or 
drug nutrient interactions. Without referral it is conceivable that such patients 
may become deficient in essential nutrients that may impact general health 
and well being. 
 
Evaluation of patients’ diet and nutritional status should be included in routine 
management of chronic OFP. Dietary advice to ensure that patients are 
consuming an adequate intake of energy, protein, and micronutrients to 
maintain general health and wellbeing is warranted.  Such advice should 
include guidance on following national dietary guidelines for health promotion 
(e.g., http://www.nhs.uk/Livewell/healthy-eating/Pages/Healthyeating.aspx) 
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and tailored to meet patients’ individual needs and other comorbidities.  
Recommendations on texture modification may be helpful for those with TMD. 
Such recommendations include peeling and chopping fresh fruits and 
vegetables and cutting and moistening meats, fish and poultry with marinades 
or natural juices. However, more research is required to ascertain the specific 
roles of different dietary components before more specialised treatment-
specific dietary advice becomes part of the everyday management of chronic 
OFP. 
 
Simple approaches to nutritional and dietary assessment for non-dietetic 
health professionals exist: 
 Screening techniques include: weighing patients and measuring their 
height in order to ascertain body mass index; inquiring about weight 
change over time; asking the patient to describe specific foods or fluids 
that they are limiting because of their chronic OFP; asking patients 
about use of special diets or dietary supplements and the rationale for 
these, and exploring any self-imposed dietary limitations; using the 
MUST tool (Malnutrition Universal Screening Tool  
(http://www.bapen.org.uk/screening-for-malnutrition/must/introducing-
must) to screen for malnutrition.  
 Simple dietary assessment - asking patients about food group intake, 
listing items like fresh fruits, vegetables, protein-rich foods (meat, fish, 
poultry, nuts and beans, vegetable protein sources like tofu), dairy 
products and fats and sugar-rich foods and drinks and comparing their 
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responses to national standards (e.g., Eatwell plate in UK and 
foodtracker.gov in USA). This simple assessment will provide some 
insight into unintentional weight change, dietary problems, diet quality, 
and can be used then to give the patient dietary guidance.  
 
Conclusion 
This commentary has highlighted the dearth of research assessing the 
various ways in which chronic OFP disorders, dietary intake, and nutrition 
may interact. Clearly there is some limited evidence for chronic OFP affecting 
dietary choice and thereby nutritional intake than for nutritional factors 
influencing pathophysiology of chronic OFP conditions. Given the strong drive 
to provide self-management techniques for chronic OFP conditions in the 
initial phases, it is somewhat surprising that more research has not been 
undertaken in relation to diet and nutrition. Evidence from other pain 
conditions suggests that an increased understanding of the role of nutrition in 
chronic OFP might help in an adjunctive capacity to improve outcomes of 
therapy. Specifically, early research needs to examine two broad areas: 1) the 
impact of chronic OFP conditions on dietary intake and nutritional status; 2) 
the impact of OFP on eating related quality of life. Once these areas have 
been examined in detail it may then be possible to identify, or rule out, any 
further research that may be required to examine the potential therapeutic role 
of specific dietary components in the management of OFP. 
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Tables 
 
Table 1 – Number of studies identified in literature for Burning mouth 
syndrome (BMS), Temporomandibular Disorders (TMD), Trigeminal 
Neuralgia (TN), and Persistent Dentoalveolar Pain Disorder (PDAP) 
using Cochrane Handbook’s highly sensitive search strategy for 
Randomised Controlled Trials (46). 
Chronic orofacial pain condition BMS TMD TN PDAP 
Total number of human and English language 
studies identified from Medline (1966 to 7 July 
2014) 
343 2700 1165 31 
Number of randomised controlled trials (RCT) 
involving nutritional or dietary intervention in one 
of the arms identified from total number of 
studies 
6 0 0 0 
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